Literature DB >> 2883650

Noncompliance in schizophrenia.

I E Babiker.   

Abstract

Compliance research is reviewed with particular reference to neuroleptic treatment of schizophrenia. Reported noncompliance rates of up to 50 per cent are likely to be an underestimate. Models of compliance and health-seeking behaviour borrowed from physical medicine are of questionable relevance to schizophrenia where perception of illness is often distorted. Factors thought to be implicated in noncompliance need to be evaluated and a theoretical model applicable to schizophrenia constructed. In the meantime there is evidence to suggest that behavioural intervention strategies may be superior to simple educational ones in the management of noncompliance. A discussion of methodological issues relating to the assessment of compliance is offered and a strategy for further research outlined.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2883650

Source DB:  PubMed          Journal:  Psychiatr Dev        ISSN: 0262-9283


  15 in total

1.  How useful is riboflavin as a tracer of medication compliance?

Authors:  I E Babiker; P R Cooke; M G Gillett
Journal:  J Behav Med       Date:  1989-02

2.  Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.

Authors:  E Diaz; H B Levine; M C Sullivan; M J Sernyak; K A Hawkins; J A Cramer; S W Woods
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

3.  Compliance therapy in psychotic patients: randomised controlled trial.

Authors:  R Kemp; P Hayward; G Applewhaite; B Everitt; A David
Journal:  BMJ       Date:  1996-02-10

4.  Medication compliance among the seriously mentally ill in a public mental health system.

Authors:  C Nageotte; G Sullivan; N Duan; P L Camp
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-02       Impact factor: 4.328

5.  Preserve and strengthen family to promote mental health.

Authors:  Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2010-04       Impact factor: 1.759

6.  Assessment of compliance-related attitudes in psychiatry. A comparison of two questionnaires based on the Health Belief Model.

Authors:  W Ludwig; D Huber; S Schmidt; W Bender; W Greil
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1990-11       Impact factor: 4.328

7.  Communication about adherence to long-term antipsychotic prescribing: an observational study of psychiatric practice.

Authors:  Alan Quirk; Rob Chaplin; Sarah Hamilton; Paul Lelliott; Clive Seale
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-09-25       Impact factor: 4.328

8.  Demographic factors associated with extreme non-compliance in schizophrenia.

Authors:  W Sellwood; N Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-07       Impact factor: 4.328

9.  Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement.

Authors:  Abigail J Herron; John J Mariani; Martina Pavlicova; Christina M Parrinello; Krysten W Bold; Frances R Levin; Edward V Nunes; Maria A Sullivan; Wilfred N Raby; Adam Bisaga
Journal:  Drug Alcohol Depend       Date:  2012-08-22       Impact factor: 4.492

10.  Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.

Authors:  Menna Alene; Michael D Wiese; Mulugeta T Angamo; Beata V Bajorek; Elias A Yesuf; Nasir Tajure Wabe
Journal:  BMC Clin Pharmacol       Date:  2012-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.